Lund Melanoma Study Group
1 – 50 of 225
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Pre- and Postoperative Antioxidant Use, Aryl Hydrocarbon Receptor (AhR) Activation and Clinical Outcome in Different Treatment Groups of Breast Cancer Patients
(
- Contribution to journal › Article
-
Mark
Potential interplay between tumor size and vitamin D receptor (VDR) polymorphisms in breast cancer prognosis : a prospective cohort study
2024) In Cancer Causes and Control(
- Contribution to journal › Article
-
Mark
Cost of Illness of Head and Neck Cancer in Sweden
2024) In Value in Health(
- Contribution to journal › Article
-
Mark
BioMEL : a translational research biobank of melanocytic lesions and melanoma
(
- Contribution to journal › Article
-
Mark
Risk factors and diagnostic tools in the skin cancer era
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Population-Based Validation of the MIA and MSKCC Tools for Predicting Sentinel Lymph Node Status
2024) In JAMA Surgery(
- Contribution to journal › Article
-
Mark
The Vitamin D Receptor as a Prognostic Marker in Breast Cancer-A Cohort Study
(
- Contribution to journal › Article
-
Mark
Molecular patterns of resistance to immune checkpoint blockade in melanoma
(
- Contribution to journal › Article
-
Mark
Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer
(
- Contribution to journal › Article
-
Mark
Time trends of the association of body mass index with mortality in 3.5 million young Swedish adults
(
- Contribution to journal › Article
-
Mark
Cohort profile : The Obesity and Disease Development Sweden (ODDS) study, a pooled cohort
(
- Contribution to journal › Article
-
Mark
High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome
(
- Contribution to journal › Article
-
Mark
The Burden of Multiple Basal Cell Carcinomas : A Population-wide Study
(
- Contribution to journal › Article
-
Mark
Acral Melanoma Incidence and Survival Trends in 1990–2020: A Nationwide, Population-based Study
(
- Contribution to journal › Article
-
Mark
Interobserver agreement on line-field confocal optical coherence tomography image markers in keratinocyte carcinomas and precursor lesions
(
- Contribution to journal › Article
-
Mark
Melanoma Incidence and Mortality Trends in Sweden
2024) In JAMA Dermatology(
- Contribution to journal › Article
- 2023
-
Mark
Immune-cell infiltration in high-grade soft tissue sarcomas; prognostic implications of tumor-associated macrophages and B-cells
(
- Contribution to journal › Article
-
Mark
South Africa and the Surgical Diaspora-A Hub for Surgical Migration and Training
(
- Contribution to journal › Article
-
Mark
Factors for not performing total body skin examinations in primary care in association with teledermoscopy
(
- Contribution to journal › Article
-
Mark
Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry
(
- Contribution to journal › Article
-
Mark
Association of metformin use and survival in patients with cutaneous melanoma and diabetes
(
- Contribution to journal › Article
-
Mark
Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer
(
- Contribution to journal › Article
-
Mark
Population-based prognostic instrument (SweMR 2.0) for melanoma-specific survival - An ideal tool for individualised treatment decisions for Swedish patients
(
- Contribution to journal › Article
-
Mark
ASO Visual Abstract : Prognostic Significance of Sentinel Lymph Node Status in Thick Primary Melanomas (> 4 mm)
(
- Contribution to journal › Published meeting abstract
-
Mark
Prognostic Significance of Sentinel Lymph Node Status in Thick Primary Melanomas (> 4 mm)
(
- Contribution to journal › Article
-
Mark
Can active sun exposure decrease the risk of giant cell arteritis and polymyalgia rheumatica in women?
(
- Contribution to journal › Article
-
Mark
Survival in patients diagnosed with melanoma in situ compared to the general population. A Swedish population-based matched cohort study
(
- Contribution to journal › Article
-
Mark
Phase II LEAP-004 Study of Lenvatinib Plus Pembrolizumab for Melanoma with Confirmed Progression on a Programmed Cell Death Protein-1 or Programmed Death Ligand 1 Inhibitor Given as Monotherapy or in Combination
(
- Contribution to journal › Article
-
Mark
A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry
(
- Contribution to journal › Article
- 2022
-
Mark
Transcriptomic signatures of tumors undergoing T cell attack
(
- Contribution to journal › Article
-
Mark
Incidence and trends of basal cell carcinoma in Sweden : A population-based registry study
(
- Contribution to journal › Article
-
Mark
Immediate increase in perceived energy after exercise during the course of chemotherapy treatment for breast cancer
(
- Contribution to journal › Article
-
Mark
Physical activity, sedentary time and breast cancer risk : a Mendelian randomisation study
(
- Contribution to journal › Article
-
Mark
Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma: A Randomized Clinical Trial
(
- Contribution to journal › Article
-
Mark
B Cells and Tertiary Lymphoid Structures : Friends or Foes in Cancer Immunotherapy?
(
- Contribution to journal › Scientific review
-
Mark
Systematic review of low-income and middle-income country perceptions of visiting surgical teams from high-income countries
(
- Contribution to journal › Scientific review
-
Mark
Dialysis as a Novel Adjuvant Treatment for Malignant Cancers
(
- Contribution to journal › Scientific review
-
Mark
No evidence that sun exposure can decrease the risk of vasculitis
2022) 20th International Vasculitis and ANCA workshop(
- Contribution to conference › Abstract
-
Mark
Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma
(
- Contribution to journal › Article
-
Mark
Quality of Life in the First Year of Follow-Up in a Randomized Multicenter Trial Assessing the Role of Imaging after Radical Surgery of Stage IIB-C and III Cutaneous Melanoma (TRIM Study)
(
- Contribution to journal › Article
-
Mark
Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes : Pooled Analysis of Population-Based Studies
(
- Contribution to journal › Article
-
Mark
Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer
(
- Contribution to journal › Article
-
Mark
DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotype
(
- Contribution to journal › Article
-
Mark
Copy number variants are ovarian cancer risk alleles at known and novel risk loci
(
- Contribution to journal › Article
- 2021
-
Mark
Multiple primary melanoma incidence trends over five decades, a nation-wide population-based study
(
- Contribution to journal › Article
-
Mark
Improved survival in several cancers with use of H1-antihistamines desloratadine and loratadine
(
- Contribution to journal › Article
-
Mark
PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma
(
- Contribution to journal › Article
-
Mark
The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy : A Population-Based Cohort Study
(
- Contribution to journal › Article
-
Mark
BRN2 is a non-canonical melanoma tumor-suppressor
(
- Contribution to journal › Article
-
Mark
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer
(
- Contribution to journal › Article